Please login to the form below

Not currently logged in
Email:
Password:

sembragiline

This page shows the latest sembragiline news and features for those working in and with pharma, biotech and healthcare.

EMA unveils draft guidelines for Alzheimer’s disease research

EMA unveils draft guidelines for Alzheimer’s disease research

Last year Roche and Evotec's sembragiline failed a phase II trial and Pfizer this week announced it has halted development of its candidate, PF-05212377, after it too failed to

Latest news

  • Roche and Evotec’s Alzheimer’s drug ineffective Roche and Evotec’s Alzheimer’s drug ineffective

    Sembragiline failed to show cognitive and memory benefits. The quest for an effective therapy for Alzheimer's disease seems to have claimed another casualty, with a drug developed by Evotec and ... Roche reports that sembragiline – a drug in the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics